UPDATE : Monday, September 7, 2020
상단여백
HOME Pharma
Daewoong compares Nabota with Botox in US, Mexico
  • By Lee Hye-seon
  • Published 2018.05.04 14:27
  • Updated 2018.05.04 14:27
  • comments 0

Daewoong Pharmaceutical is actively promoting Nabota, an injectable type A botulinum toxin, by presenting its latest clinical results at academic events in the U.S. and Mexico.

The Korean drugmaker revealed the results of the comparative studies on Nabota and original treatment Botox, at the meeting of the American Society for Aesthetic Plastic Surgery in New York from Thursday to Tuesday.

The disclosed studies were phase-3 EVB-003 trials in Europe and Canada, and long-term safety trials EVB-004 in the U.S.

Nabota proved non-inferiority of efficacy compared to Botox in 520 participants in the EVB-003 study, according to European clinical researcher Per Heden. In the EVB-004 trials in the U.S., Nabota proved its safety and efficacy through a 12-month repeated dose, said Paul Lorenc, one of the U.S. clinical researchers.

Daewoong also disclosed Nabota’s clinical results and introduced various procedures such as “Nobolift,” at the Reunion Annual de Dermatologos Latinoamericano 2018 in Cancun, Mexico, from Saturday to Tuesday.

“With Nabota’s latest clinical results, promotion, and exhibitions, we will not only expand our business in Asia and Central and South America but accelerate market entry into the U.S. and Europe,” said Park Seong-soo, head of Nabota business division at Daewoong.

Nabota is in the fourth year of its sales this year. Daewoong started selling the anti-wrinkle product in Panama in 2014 and has expanded sales in nine countries, including Mexico in 2017.

Daewoong aims to enlarge market shares in Central and South America including Brazil and to make Nabota a global brand by entering advanced markets such as the U.S., Europe and Canada.

lhs@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Lee Hye-seon
iconMost viewed
Comments 0
More
Please leave the first comment.
여백
여백
여백
Back to Top